533 related articles for article (PubMed ID: 36218065)
1. Emerging degrader technologies engaging lysosomal pathways.
Ding Y; Xing D; Fei Y; Lu B
Chem Soc Rev; 2022 Oct; 51(21):8832-8876. PubMed ID: 36218065
[TBL] [Abstract][Full Text] [Related]
2. Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs.
Alabi SB; Crews CM
J Biol Chem; 2021; 296():100647. PubMed ID: 33839157
[TBL] [Abstract][Full Text] [Related]
3. Autophagy mediated targeting degradation, a promising strategy in drug development.
Zhang J; Pan X; Ji W; Zhou J
Bioorg Chem; 2024 Aug; 149():107466. PubMed ID: 38843684
[TBL] [Abstract][Full Text] [Related]
4. Emerging New Concepts of Degrader Technologies.
Ding Y; Fei Y; Lu B
Trends Pharmacol Sci; 2020 Jul; 41(7):464-474. PubMed ID: 32416934
[TBL] [Abstract][Full Text] [Related]
5. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.
Fang Y; Wang J; Zhao M; Zheng Q; Ren C; Wang Y; Zhang J
J Med Chem; 2022 Sep; 65(17):11454-11477. PubMed ID: 36006861
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches to targeted protein degradation technologies in drug discovery.
Xue Y; Bolinger AA; Zhou J
Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
[TBL] [Abstract][Full Text] [Related]
7. Multifaceted targeted protein degradation systems for different cellular compartments.
Zorca CE; Fallahi A; Luo S; Eldeeb MA
Bioessays; 2022 Jun; 44(6):e2200008. PubMed ID: 35417040
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
Zheng ZG; Zhu ST; Cheng HM; Zhang X; Cheng G; Thu PM; Wang SP; Li HJ; Ding M; Qiang L; Chen XW; Zhong Q; Li P; Xu X
Autophagy; 2021 Jul; 17(7):1592-1613. PubMed ID: 32432943
[TBL] [Abstract][Full Text] [Related]
9. Targeting the undruggables-the power of protein degraders.
Zhang C; Liu Y; Li G; Yang Z; Han C; Sun X; Sheng C; Ding K; Rao Y
Sci Bull (Beijing); 2024 Jun; 69(11):1776-1797. PubMed ID: 38614856
[TBL] [Abstract][Full Text] [Related]
10. Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
Lin J; Jin J; Shen Y; Zhang L; Gong G; Bian H; Chen H; Nagle DG; Wu Y; Zhang W; Luan X
Theranostics; 2021; 11(17):8337-8349. PubMed ID: 34373745
[TBL] [Abstract][Full Text] [Related]
11. Degradation of lipid droplets by chimeric autophagy-tethering compounds.
Fu Y; Chen N; Wang Z; Luo S; Ding Y; Lu B
Cell Res; 2021 Sep; 31(9):965-979. PubMed ID: 34239073
[TBL] [Abstract][Full Text] [Related]
12. Advancing targeted protein degradation for metabolic diseases therapy.
Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
[TBL] [Abstract][Full Text] [Related]
13. Bioorthogonal Aptamer-ATTEC Conjugates for Degradation of Alpha-Synuclein via Autophagy-Lysosomal Pathway.
Liao X; Qin G; Liu Z; Ren J; Qu X
Small; 2024 Feb; 20(8):e2306760. PubMed ID: 37821404
[TBL] [Abstract][Full Text] [Related]
14. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
[TBL] [Abstract][Full Text] [Related]
15. Targeted protein degradation in drug development: Recent advances and future challenges.
Song J; Hu M; Zhou J; Xie S; Li T; Li Y
Eur J Med Chem; 2023 Dec; 261():115839. PubMed ID: 37778240
[TBL] [Abstract][Full Text] [Related]
16. Targeted protein degrader development for cancer: advances, challenges, and opportunities.
Fang Y; Wang S; Han S; Zhao Y; Yu C; Liu H; Li N
Trends Pharmacol Sci; 2023 May; 44(5):303-317. PubMed ID: 37059054
[TBL] [Abstract][Full Text] [Related]
17. Major Advances in Emerging Degrader Technologies.
Luo H; Wu L; He Y; Qin C; Tang X
Front Cell Dev Biol; 2022; 10():921958. PubMed ID: 35813205
[TBL] [Abstract][Full Text] [Related]
18. Nucleic-Acid-Based Targeted Degradation in Drug Discovery.
Wang W; He S; Dong G; Sheng C
J Med Chem; 2022 Aug; 65(15):10217-10232. PubMed ID: 35916496
[TBL] [Abstract][Full Text] [Related]
19. A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy.
Wang J; Wang Y; Yang F; Luo Q; Hou Z; Xing Y; Lu F; Li Z; Yin F
ACS Chem Biol; 2024 May; 19(5):1161-1168. PubMed ID: 38662199
[TBL] [Abstract][Full Text] [Related]
20. PROTAC targeted protein degraders: the past is prologue.
Békés M; Langley DR; Crews CM
Nat Rev Drug Discov; 2022 Mar; 21(3):181-200. PubMed ID: 35042991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
